AEON Global Health Corp. (AGHC)
Stock Price:
$0.0600 USD
-0.0050 (-7.69%)
Updated Aug 3, 2020 5:19 PM EDT - End of day
Key Info
| Market Cap |
594,904 |
| Revenue (ttm) |
12.93M |
| Net Income (ttm) |
-7.98M |
| Shares Out |
9.92M |
| EPS (ttm) |
-1.01 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 3, 2020 |
| Last Price |
$0.0600 |
| Previous Close |
$0.0650 |
| Change ($) |
-0.0050 |
| Change (%) |
-7.69% |
| Day's Open |
0.0600 |
| Day's Range |
0.0600 - 0.0600 |
| Day's Volume |
444 |
| 52-Week Range |
0.0225 - 0.2480 |
More Stats
| Market Cap |
594,904 |
| Enterprise Value |
2.95M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
9.92M |
| Float |
5.15M |
| EPS (basic) |
-1.01 |
| EPS (diluted) |
-1.01 |
| FCF / Share |
0.00 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
5.08% |
| Payout Ratio |
n/a |
| Shares Short |
29,011 |
| Short Ratio |
1.52 |
| Short % of Float |
0.76% |
| Beta |
0.57 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
19.67 |
| PS Ratio |
0.05 |
| PB Ratio |
n/a |
| Revenue |
12.93M |
| Operating Income |
-3.06M |
| Net Income |
-7.98M |
| Free Cash Flow |
30,238 |
| Net Cash |
-2.36M |
| Net Cash / Share |
-0.24 |
| Gross Margin |
61.26% |
| Operating Margin |
-23.69% |
| Profit Margin |
-64.30% |
| FCF Margin |
0.23% |
| ROA |
-24.77% |
| ROE |
n/a |
| ROIC |
-49.50% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
1.90
Current: $0.0600
High
1.90
Target: 1.90
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 12.93 | 16.30 | 20.20 | 34.58 | 24.45 | 5.56 | 4.83 | 3.19 | 2.94 | 2.43 |
| Revenue Growth | -20.67% | -19.3% | -41.58% | 41.45% | 339.98% | 15.1% | 51.41% | 8.58% | 20.97% | - |
| Gross Profit | 7.92 | 11.17 | 16.00 | 27.70 | 20.22 | 1.80 | 1.37 | 0.60 | 0.94 | 0.41 |
| Operating Income | -3.06 | -0.99 | -5.38 | 5.80 | 10.39 | -7.12 | -7.37 | -7.71 | -7.15 | -8.88 |
| Net Income | -7.98 | -8.00 | -32.07 | 5.27 | 9.24 | -7.14 | -11.35 | -8.35 | -12.56 | -9.01 |
| Shares Outstanding | 8.20 | 7.25 | 7.19 | 2.98 | 0.96 | 4.26 | 3.41 | 3.00 | 2.56 | 2.14 |
| Earnings Per Share | -1.01 | -1.15 | -4.51 | 1.32 | 9.64 | -2.34 | -4.05 | -3.15 | -5.31 | -4.50 |
| EPS Growth | - | - | - | -86.31% | - | - | - | - | - | - |
| Operating Cash Flow | 0.04 | -1.01 | 0.54 | 7.92 | 9.13 | -4.73 | -5.21 | -6.51 | -6.47 | -8.11 |
| Capital Expenditures | -0.01 | -0.02 | -0.02 | -1.73 | -0.55 | -0.32 | -0.27 | -0.51 | -0.61 | -0.40 |
| Free Cash Flow | 0.03 | -1.03 | 0.51 | 6.19 | 8.58 | -5.05 | -5.49 | -7.02 | -7.08 | -8.51 |
| Cash & Equivalents | 0.75 | 0.72 | 1.24 | 1.54 | 5.24 | 1.55 | 3.97 | 2.50 | 2.68 | 1.61 |
| Total Debt | 3.11 | 3.05 | 2.55 | 2.98 | - | - | 0.72 | 2.87 | - | - |
| Net Cash / Debt | -2.36 | -2.33 | -1.30 | -1.44 | 5.24 | 1.55 | 3.25 | -0.36 | 2.68 | 1.61 |
| Assets | 3.91 | 10.98 | 16.73 | 51.67 | 7.83 | 8.23 | 13.19 | 12.86 | 10.84 | 20.54 |
| Liabilities | 9.89 | 10.49 | 8.70 | 11.73 | 2.43 | 3.01 | 4.52 | 6.79 | 3.43 | 5.67 |
| Book Value | -5.98 | 0.49 | 8.03 | 39.94 | 5.40 | 5.22 | 8.68 | 2.81 | 4.47 | 14.88 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
AEON Global Health Corp. |
| Country |
United States |
| Employees |
52 |
| CEO |
Hanif A. Roshan |
Stock Information
| Ticker Symbol |
AGHC |
| Stock Exchange |
US OTC |
| Sector |
Healthcare |
| Industry |
Diagnostics & Research |
| Unique Identifier |
OTCMKTS: AGHC |
Description
Aeon Global Health Corp., together with its subsidiaries, provides various clinical laboratory testing services in the United States. The company operates through Laboratory Testing Services and Web-Based Software segments. Its laboratory testing services include the testing of an individual's blood, urine, or saliva for the presence of drugs or chemicals, as well as the patient's DNA profile. The company primarily offers medical toxicology, DNA pharmacogenomics, cancer genetic testing, and molecular biology tests. It also provides Web-based services as software as a service for Web-based revenue cycle management applications; and telehealth products and services that enable healthcare organizations to coordinate care for patients, and enhance related administrative and clinical workflows, as well as compliance with regulatory requirements. The company was formerly known as Authentidate Holding Corp. and changed its name to Aeon Global Health Corp. in January 2018. Aeon Global Health Corp. is headquartered in Gainesville, Georgia.